• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大量被认为是致病性的遗传变异在无症状个体中很常见。

Large numbers of genetic variants considered to be pathogenic are common in asymptomatic individuals.

机构信息

Brigham and Women's Hospital, Division of Genetics Boston, Massachusetts, USA.

出版信息

Hum Mutat. 2013 Sep;34(9):1216-20. doi: 10.1002/humu.22375. Epub 2013 Aug 5.

DOI:10.1002/humu.22375
PMID:23818451
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3786140/
Abstract

It is now affordable to order clinically interpreted whole-genome sequence reports from clinical laboratories. One major component of these reports is derived from the knowledge base of previously identified pathogenic variants, including research articles, locus-specific, and other databases. While over 150,000 such pathogenic variants have been identified, many of these were originally discovered in small cohort studies of affected individuals, so their applicability to asymptomatic populations is unclear. We analyzed the prevalence of a large set of pathogenic variants from the medical and scientific literature in a large set of asymptomatic individuals (N = 1,092) and found 8.5% of these pathogenic variants in at least one individual. In the average individual in the 1000 Genomes Project, previously identified pathogenic variants occur on average 294 times (σ = 25.5) in homozygous form and 942 times (σ = 68.2) in heterozygous form. We also find that many of these pathogenic variants are frequently occurring: there are 3,744 variants with minor allele frequency (MAF) ≥ 0.01 (4.6%) and 2,837 variants with MAF ≥ 0.05 (3.5%). This indicates that many of these variants may be erroneous findings or have lower penetrance than previously expected.

摘要

现在,从临床实验室订购经过临床解读的全基因组序列报告已经变得负担得起。这些报告的一个主要组成部分来自先前确定的致病性变异知识库,包括研究文章、特定基因座和其他数据库。虽然已经确定了超过 150,000 个这样的致病性变异,但其中许多最初是在受影响个体的小队列研究中发现的,因此它们对无症状人群的适用性尚不清楚。我们分析了大量无症状个体(N=1092)的大量来自医学和科学文献中的致病性变异的流行率,并在至少一个个体中发现了 8.5%的这些致病性变异。在 1000 基因组计划中的平均个体中,先前确定的致病性变异在纯合形式下平均出现 294 次(σ=25.5),在杂合形式下平均出现 942 次(σ=68.2)。我们还发现,其中许多致病性变异是高频发生的:有 3744 个变异的次要等位基因频率(MAF)≥0.01(4.6%),有 2837 个变异的 MAF≥0.05(3.5%)。这表明,其中许多变异可能是错误的发现,或者比以前预期的穿透率更低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6686/3786140/9099624ff491/nihms-515662-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6686/3786140/4cf8ac18a641/nihms-515662-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6686/3786140/3dd06919a999/nihms-515662-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6686/3786140/4f027e0bebc9/nihms-515662-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6686/3786140/3b60488666e1/nihms-515662-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6686/3786140/9099624ff491/nihms-515662-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6686/3786140/4cf8ac18a641/nihms-515662-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6686/3786140/3dd06919a999/nihms-515662-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6686/3786140/4f027e0bebc9/nihms-515662-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6686/3786140/3b60488666e1/nihms-515662-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6686/3786140/9099624ff491/nihms-515662-f0005.jpg

相似文献

1
Large numbers of genetic variants considered to be pathogenic are common in asymptomatic individuals.大量被认为是致病性的遗传变异在无症状个体中很常见。
Hum Mutat. 2013 Sep;34(9):1216-20. doi: 10.1002/humu.22375. Epub 2013 Aug 5.
2
Incidentalome from Genomic Sequencing: A Barrier to Personalized Medicine?基因组测序的偶然发现:对个性化医疗的阻碍?
EBioMedicine. 2016 Feb 4;5:211-6. doi: 10.1016/j.ebiom.2016.01.030. eCollection 2016 Mar.
3
Actionable, pathogenic incidental findings in 1,000 participants' exomes.1000 名参与者外显子组中的可操作、致病性偶然发现。
Am J Hum Genet. 2013 Oct 3;93(4):631-40. doi: 10.1016/j.ajhg.2013.08.006. Epub 2013 Sep 19.
4
Whole-genome sequencing identifies EN1 as a determinant of bone density and fracture.全基因组测序确定EN1是骨密度和骨折的一个决定因素。
Nature. 2015 Oct 1;526(7571):112-7. doi: 10.1038/nature14878. Epub 2015 Sep 14.
5
Using Whole Exome Sequencing to Identify Candidate Genes With Rare Variants In Nonsyndromic Cleft Lip and Palate.利用全外显子组测序鉴定非综合征性唇腭裂中具有罕见变异的候选基因。
Genet Epidemiol. 2016 Jul;40(5):432-41. doi: 10.1002/gepi.21972. Epub 2016 May 27.
6
Utilizing ethnic-specific differences in minor allele frequency to recategorize reported pathogenic deafness variants.利用次要等位基因频率的种族特异性差异对已报道的致病性耳聋变异进行重新分类。
Am J Hum Genet. 2014 Oct 2;95(4):445-53. doi: 10.1016/j.ajhg.2014.09.001. Epub 2014 Sep 25.
7
Pathogenic variant burden in the ExAC database: an empirical approach to evaluating population data for clinical variant interpretation.ExAC数据库中的致病变异负担:一种评估群体数据用于临床变异解读的实证方法。
Genome Med. 2017 Feb 6;9(1):13. doi: 10.1186/s13073-017-0403-7.
8
A comparison of cataloged variation between International HapMap Consortium and 1000 Genomes Project data.国际人类基因组单体型图计划与 1000 基因组计划数据中已编目的变异比较。
J Am Med Inform Assoc. 2012 Mar-Apr;19(2):289-94. doi: 10.1136/amiajnl-2011-000652.
9
Penetrance and expressivity of mitochondrial variants in a large clinically unselected population.未经过临床筛选的大规模人群中线粒体变异的外显率和表现度
Hum Mol Genet. 2024 Feb 18;33(5):465-474. doi: 10.1093/hmg/ddad194.
10
Clinical interpretation and implications of whole-genome sequencing.全基因组测序的临床解读及意义。
JAMA. 2014 Mar 12;311(10):1035-45. doi: 10.1001/jama.2014.1717.

引用本文的文献

1
Extracting and calibrating evidence of variant pathogenicity from population biobank data.从人群生物样本库数据中提取和校准变异致病性的证据。
Am J Hum Genet. 2025 Jul 4. doi: 10.1016/j.ajhg.2025.06.012.
2
A genotype-first approach identifies high incidence of NF1 pathogenic variants with distinct disease associations.一种先从基因型入手的方法发现,神经纤维瘤病1型(NF1)致病变异的发生率很高,且与不同的疾病相关。
Nat Commun. 2025 Apr 1;16(1):3121. doi: 10.1038/s41467-025-57077-1.
3
International policies guiding the selection, analysis, and clinical management of secondary findings from genomic sequencing: A systematic review.国际政策指导基因组测序中次生发现的选择、分析和临床管理:系统评价。
Am J Hum Genet. 2024 Oct 3;111(10):2079-2093. doi: 10.1016/j.ajhg.2024.08.012. Epub 2024 Sep 18.
4
Evaluating the association of biallelic OGDHL variants with significant phenotypic heterogeneity.评估双等位基因 OGDHL 变异与显著表型异质性的关联。
Genome Med. 2023 Nov 29;15(1):102. doi: 10.1186/s13073-023-01258-4.
5
ClinVar and HGMD genomic variant classification accuracy has improved over time, as measured by implied disease burden.ClinVar 和 HGMD 基因组变异分类的准确性随着时间的推移有所提高,这可以通过潜在疾病负担来衡量。
Genome Med. 2023 Jul 13;15(1):51. doi: 10.1186/s13073-023-01199-y.
6
Estimating clinical risk in gene regions from population sequencing cohort data.从人群测序队列数据中估算基因区域的临床风险。
Am J Hum Genet. 2023 Jun 1;110(6):940-949. doi: 10.1016/j.ajhg.2023.05.003. Epub 2023 May 25.
7
Modeling of -Based Podocytopathy Using Nephrocytes.使用肾细胞对基于 - 的足细胞病进行建模。 (你提供的原文中“-Based”部分有缺失内容,以上译文是根据现有内容尽量完整翻译的)
Kidney Int Rep. 2022 Oct 31;8(2):317-329. doi: 10.1016/j.ekir.2022.10.024. eCollection 2023 Feb.
8
Estimating clinical risk in gene regions from population sequencing cohort data.从群体测序队列数据估计基因区域的临床风险。
medRxiv. 2023 Jan 9:2023.01.06.23284281. doi: 10.1101/2023.01.06.23284281.
9
A pipeline-friendly software tool for genome diagnostics to prioritize genes by matching patient symptoms to literature.一种适用于基因组诊断的对流水线友好的软件工具,通过将患者症状与文献匹配来对基因进行优先级排序。
Adv Genet (Hoboken). 2020 Aug 10;1(1):e10023. doi: 10.1002/ggn2.10023. eCollection 2020 Dec.
10
Clinical exome-based panel testing for medically actionable secondary findings in a cohort of 383 Italian participants.针对383名意大利参与者队列进行基于临床外显子组的基因检测板检测,以发现具有医学可操作性的次要发现。
Front Genet. 2022 Nov 10;13:956723. doi: 10.3389/fgene.2022.956723. eCollection 2022.

本文引用的文献

1
NCBI's Database of Genotypes and Phenotypes: dbGaP.NCBI 的基因型和表型数据库:dbGaP。
Nucleic Acids Res. 2014 Jan;42(Database issue):D975-9. doi: 10.1093/nar/gkt1211. Epub 2013 Dec 1.
2
Predicting functional effect of human missense mutations using PolyPhen-2.使用PolyPhen-2预测人类错义突变的功能效应。
Curr Protoc Hum Genet. 2013 Jan;Chapter 7:Unit7.20. doi: 10.1002/0471142905.hg0720s76.
3
Calibration of multiple in silico tools for predicting pathogenicity of mismatch repair gene missense substitutions.多种用于预测错配修复基因错义替换致病变异体预测的计算机模拟工具的校准。
Hum Mutat. 2013 Jan;34(1):255-65. doi: 10.1002/humu.22214. Epub 2012 Oct 22.
4
The Human Gene Mutation Database (HGMD) and its exploitation in the fields of personalized genomics and molecular evolution.人类基因突变数据库(HGMD)及其在个性化基因组学和分子进化领域的应用。
Curr Protoc Bioinformatics. 2012 Sep;Chapter 1:1.13.1-1.13.20. doi: 10.1002/0471250953.bi0113s39.
5
Medicine. Whole-genome sequencing: the new standard of care?医学。全基因组测序:新的治疗标准?
Science. 2012 Jun 1;336(6085):1112-3. doi: 10.1126/science.1220967.
6
An abundance of rare functional variants in 202 drug target genes sequenced in 14,002 people.在 14002 个人中对 202 个药物靶标基因进行测序,发现了大量罕见的功能变异。
Science. 2012 Jul 6;337(6090):100-4. doi: 10.1126/science.1217876. Epub 2012 May 17.
7
Recent explosive human population growth has resulted in an excess of rare genetic variants.最近人类人口的爆炸式增长导致了罕见遗传变异体的过剩。
Science. 2012 May 11;336(6082):740-3. doi: 10.1126/science.1217283.
8
What's a Genome Worth?基因组的价值是多少?
Sci Transl Med. 2012 May 9;4(133):133fs13. doi: 10.1126/scitranslmed.3004208.
9
The predictive capacity of personal genome sequencing.个人基因组测序的预测能力。
Sci Transl Med. 2012 May 9;4(133):133ra58. doi: 10.1126/scitranslmed.3003380. Epub 2012 Apr 2.
10
Taxonomizing, sizing, and overcoming the incidentalome.分类、定标和克服偶然发现。
Genet Med. 2012 Apr;14(4):399-404. doi: 10.1038/gim.2011.68. Epub 2012 Feb 9.